9-4117942-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001042413.2(GLIS3):​c.1536C>A​(p.Asp512Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0168 in 1,614,060 control chromosomes in the GnomAD database, including 303 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 36 hom., cov: 31)
Exomes 𝑓: 0.017 ( 267 hom. )

Consequence

GLIS3
NM_001042413.2 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 0.871

Publications

10 publications found
Variant links:
Genes affected
GLIS3 (HGNC:28510): (GLIS family zinc finger 3) This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear protein with five C2H2-type zinc finger domains. This protein functions as both a repressor and activator of transcription and is specifically involved in the development of pancreatic beta cells, the thyroid, eye, liver and kidney. Mutations in this gene have been associated with neonatal diabetes and congenital hypothyroidism (NDH). Alternatively spliced variants that encode different protein isoforms have been described but the full-length nature of only two have been determined. [provided by RefSeq, Jul 2008]
GLIS3 Gene-Disease associations (from GenCC):
  • neonatal diabetes mellitus with congenital hypothyroidism
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001042413.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0039258897).
BP6
Variant 9-4117942-G-T is Benign according to our data. Variant chr9-4117942-G-T is described in ClinVar as Benign. ClinVar VariationId is 129158.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.014 (2133/152280) while in subpopulation SAS AF = 0.0211 (102/4826). AF 95% confidence interval is 0.0181. There are 36 homozygotes in GnomAd4. There are 1076 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 36 AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001042413.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLIS3
NM_001042413.2
MANE Select
c.1536C>Ap.Asp512Glu
missense
Exon 4 of 11NP_001035878.1Q8NEA6-2
GLIS3
NM_001438906.1
c.1536C>Ap.Asp512Glu
missense
Exon 4 of 11NP_001425835.1
GLIS3
NM_001438907.1
c.1536C>Ap.Asp512Glu
missense
Exon 4 of 11NP_001425836.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GLIS3
ENST00000381971.8
TSL:5 MANE Select
c.1536C>Ap.Asp512Glu
missense
Exon 4 of 11ENSP00000371398.3Q8NEA6-2
GLIS3
ENST00000324333.14
TSL:1
c.1071C>Ap.Asp357Glu
missense
Exon 3 of 10ENSP00000325494.10Q8NEA6-1
GLIS3
ENST00000467497.6
TSL:1
n.76C>A
non_coding_transcript_exon
Exon 1 of 6

Frequencies

GnomAD3 genomes
AF:
0.0140
AC:
2136
AN:
152162
Hom.:
36
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00241
Gnomad AMI
AF:
0.0614
Gnomad AMR
AF:
0.00576
Gnomad ASJ
AF:
0.00663
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.0215
Gnomad FIN
AF:
0.0419
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0190
Gnomad OTH
AF:
0.0124
GnomAD2 exomes
AF:
0.0167
AC:
4187
AN:
251232
AF XY:
0.0180
show subpopulations
Gnomad AFR exome
AF:
0.00240
Gnomad AMR exome
AF:
0.00353
Gnomad ASJ exome
AF:
0.00774
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0391
Gnomad NFE exome
AF:
0.0200
Gnomad OTH exome
AF:
0.0135
GnomAD4 exome
AF:
0.0171
AC:
24949
AN:
1461780
Hom.:
267
Cov.:
39
AF XY:
0.0177
AC XY:
12838
AN XY:
727188
show subpopulations
African (AFR)
AF:
0.00248
AC:
83
AN:
33480
American (AMR)
AF:
0.00385
AC:
172
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00869
AC:
227
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0249
AC:
2147
AN:
86258
European-Finnish (FIN)
AF:
0.0367
AC:
1955
AN:
53326
Middle Eastern (MID)
AF:
0.0101
AC:
58
AN:
5768
European-Non Finnish (NFE)
AF:
0.0175
AC:
19474
AN:
1111992
Other (OTH)
AF:
0.0138
AC:
833
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1469
2939
4408
5878
7347
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
680
1360
2040
2720
3400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0140
AC:
2133
AN:
152280
Hom.:
36
Cov.:
31
AF XY:
0.0144
AC XY:
1076
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00241
AC:
100
AN:
41560
American (AMR)
AF:
0.00575
AC:
88
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00663
AC:
23
AN:
3470
East Asian (EAS)
AF:
0.000387
AC:
2
AN:
5164
South Asian (SAS)
AF:
0.0211
AC:
102
AN:
4826
European-Finnish (FIN)
AF:
0.0419
AC:
445
AN:
10612
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0190
AC:
1290
AN:
68032
Other (OTH)
AF:
0.0123
AC:
26
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
115
230
345
460
575
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0171
Hom.:
91
Bravo
AF:
0.0111
Asia WGS
AF:
0.0120
AC:
43
AN:
3478
EpiCase
AF:
0.0183
EpiControl
AF:
0.0162

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
4
not specified (4)
-
-
1
Diabetes mellitus (1)
-
-
1
Monogenic diabetes (1)
-
-
1
Neonatal diabetes mellitus with congenital hypothyroidism (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.21
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.080
T
Eigen
Benign
-0.35
Eigen_PC
Benign
-0.18
FATHMM_MKL
Benign
0.49
N
LIST_S2
Benign
0.52
T
MetaRNN
Benign
0.0039
T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.97
L
PhyloP100
0.87
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
-0.24
N
REVEL
Benign
0.12
Sift
Benign
0.37
T
Sift4G
Benign
1.0
T
Varity_R
0.049
gMVP
0.32
Mutation Taster
=96/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs148199056;
hg19: chr9-4117942;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.